European Diabetes Diagnostics Market

Publication Date	December 2008
Publisher	Frost & Sullivan
Product Type	Report
Pages	91
ISBN Number	not applicable
Product Code	FRS01047

Buy this product or for assistance call +44 20 7060 7474

PDF £3,910.00$6504 | €4376

FAX Order above formats by FAX

Summary

Self-monitoring and POC Diabetes Tests Offer Promise of Significant Growth

The European diabetes diagnostics market is poised for expansion with segments such as self-monitoring and POC tests offering tremendous growth potential. Heightened efforts to generate awareness about diabetes and related diagnostic tests are a key driver in market development. For instance, limited awareness about HbA1C tests is restraining the laboratory market. However, this challenge will be curtailed with more education about the test. The increasing prevalence of diabetes along with the demand for more rapid tests drives the market, especially for the SMBG segment, notes the analyst of this research. Efforts are being undertaken to popularise HbA1C tests and enhance the adoption rate in POC settings. Type-2 diabetes is asymptomatic in nature; therefore, emphasis is placed on early diagnosis of the disease. Along with early diagnosis, patients are recommended to use self-test meters at home. The rising interest in self-testing has opened opportunities for emerging technologies such as minimally invasive and non-invasive blood glucose meters.

Low Awareness Levels Need to be Overcome to Maximise Growth Potential

Low awareness and poor communication between manufacturers and physicians is a challenge for the HbA1C market. Different laboratories have varied methods of measuring HbA1C, leading to inconsistency in results. Manufacturers must diversify into other segments in order to maintain growth momentum in the diabetes diagnostics market, explains the analyst. Improved coordination between physicians and the patient community is the best way to produce customised solutions in the market. In addition to high-quality products, market participants must provide additional support to end users. Round-the-clock customer service and exceptional technical support are essential to succeed in this fiercely competitive market. Manufacturers must create awareness about the importance of diabetes diagnostics tests, says the analyst. Resources need to be allocated exclusively for marketing and distribution services.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

Laboratory HbA1C testing
Self-monitoring blood glucose (SMBG)
Point-of-care (POC) diabetes testing

Content

1 EXECUTIVE SUMMARY
- Executive Summary
  - 1. Executive Summary
2 GLOSSARY TERMS AND EXCHANGE RATES
- Glossary Terms and Exchange Rates
  - 1. Glossary of Terms
  - 2. Exchange Rates
3 INDUSTRY CHALLENGES
- Industry Challenges
  - 1. Industry Challenges
4 EUROPEAN DIABETES DIAGNOSTICS MARKET
- Forecasts for European Diabetes Diagnostics Market
  - 1. Market Overview
  - 2. Research Methodology
  - 3. Market Segmentation
  - 4. Measurements
  - 5. Market Drivers
  - 6. Market Restraints
  - 7. Segment Dynamics
  - 8. Revenue Forecasts
  - 9. Technology Trends
  - 10. End-user Trends
  - 11. Geographic Trends-I
  - 12. Geographic Trends-II
  - 13. Market Analysis
5 MARKET ENGINEERING STRATEGIC RECOMMENDATIONS
- Strategic Recommendations
  - 1. Strategic Recommendations
6 DATABASE OF KEY INDUSTRY PARTICIPANTS
- Database of Key Industry Participants
  - 1. Database of Key Industry Participants
7 DECISION SUPPORT DATABASE
- Decision Support Database
  - 1. Diabetes Incidence
  - 2. Diabetes Prevalence
  - 3. Diabetes Prevalence as a Percent of Total Population
  - 4. Number of Hospitals
  - 5. Number of Physicians
List of Figures
Chapter
- Exchange rates in Europe in 2008
Chapter
- Impact of top industry challenges in the European diabetes diagnostics market from 2009 to 2015
Chapter
- Prevalence of diabetes mellitus in Europe in 2007 and 2025
- Market drivers ranked in order of impact in the European diabetes diagnostics market from 2009 to 2015
- Market restraints ranked in order of impact in the European diabetes diagnostics market from 2009 to 2015
- Market driver and its impact in the European laboratory-based HbA1c diabetes diagnostics market from 2009 to 2015
- Market restraint and its impact in the European laboratory-based HbA1c diabetes diagnostics market from 2009 to 2015
- Market drivers ranked in order of impact in the European SMBG diabetes diagnostics market from 2009 to 2015
- Market restraints ranked in order of impact in the European SMBG diabetes diagnostics market from 2009 to 2015
- Market driver and its impact in the European POCT diabetes diagnostics market from 2009 to 2015
- Market restraint and its impact in the European POCT diabetes diagnostics market from 2009 to 2015
- Revenue forecasts for the European diabetes diagnostics market from 2005 to 2015
- Revenue forecasts for the European laboratory-based HbA1c diabetes diagnostics market from 2005 to 2015
- Revenue forecasts for the European SMBG diabetes diagnostics market from 2005 to 2015
- Comprehensive calculation of market potential for the European SMBG diabetes diagnostics market in 2008
- Revenue forecasts for the European POCT diabetes diagnostics market from 2005 to 2015
- Per cent revenues by segment for the European POCT diabetes diagnostics market from 2005 to 2015
- Competitive structure of the European diabetes diagnostics market in 2008
- Market share trends of major market participants in the European diabetes diagnostics market in 2008
- Competitive structure of the European laboratory-based HbA1c diabetes diagnostics market in 2008
- Competitive structure of the European SMBG diabetes diagnostics market in 2008
- Market share trends of major market participants in the European SMBG diabetes diagnostics market in 2008
- Product portfolio of leading market participants in the European SMBG diabetes diagnostics market in 2008
- Competitive ranking table of leading market participants in the European SMBG diabetes diagnostics market in 2008
- Competitive structure of the European POCT diabetes diagnostics market in 2008
- Market share trends of major market participants in the European POCT diabetes diagnostics market in 2008
Chapter
- Major strategic recommendations for the European diabetes diagnostics market in 2008
Chapter
- Diabetes incidence in '000 in Europe from 2002 to 2012
- Diabetes prevalence in '000 in Europe from 2002 to 2012
- Diabetes prevalence as a percentage of total population from 2002 to 2012
- Number of hospitals in '000 in Europe from 2002 to 2012
- Number of physicians in '000 in Europe from 2002 to 2012